Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4006 AL 4020

Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease

Agrawal M, Ajazuddin, Tripathi DK, Saraf S, Saraf S, Antimisiaris SG, Mourtas S, Hammarlund-Udenaes M, Alexander A.

J Control Release. 2017 Aug 28;260:61-77. doi: 10.1016/j.jconrel.2017.05.019. Epub 2017 May 24.

Targeting Free Radicals in Oxidative Stress-Related Human Diseases

Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M.

Trends Pharmacol Sci. 2017 Jul;38(7):592-607. doi: 10.1016/j.tips.2017.04.005. Epub 2017 May 24.

Biosensors for Screening Kinase Inhibitors

Bhalla N, Estrela P.

Curr Top Med Chem. 2017;17(22):2470-2481. doi: 10.2174/1568026617666170531113233.

The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models

Amit T, Bar-Am O, Mechlovich D, Kupershmidt L, Youdim MBH, Weinreb O.

Neuropharmacology. 2017 Sep 1;123:359-367. doi: 10.1016/j.neuropharm.2017.05.026. Epub 2017 May 29.

[Cataract surgery among 50 Alzheimer's patient (55 eyes)]

Girard B, Chouard B, Hardy F.

J Fr Ophtalmol. 2017 Jun;40(6):487-498. doi: 10.1016/j.jfo.2017.01.006. Epub 2017 May 29.

Cognitive training in Alzheimer's disease: a controlled randomized study

Giovagnoli AR, Manfredi V, Parente A, Schifano L, Oliveri S, Avanzini G.

Neurol Sci. 2017 Aug;38(8):1485-1493. doi: 10.1007/s10072-017-3003-9. Epub 2017 Jun 2.

Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease

Shoaib M, Kamal MA, Rizvi SMD.

Curr Drug Metab. 2017;18(9):842-852. doi: 10.2174/1389200218666170607101622.

Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease

Nesi G, Sestito S, Digiacomo M, Rapposelli S.

Curr Top Med Chem. 2017;17(27):3062-3079. doi: 10.2174/1568026617666170607114232.

The amyloid beta-precursor protein-The unappreciated cerebral anticoagulant

Schmaier AH.

Thromb Res. 2017 Jul;155:149-151. doi: 10.1016/j.thromres.2017.05.037. Epub 2017 Jun 2.

Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse"

Thambisetty M.

Am J Physiol Cell Physiol. 2017 Oct 1;313(4):C353-C361. doi: 10.1152/ajpcell.00111.2017. Epub 2017 Jun 14.

Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study

Törmälehto S, Martikainen J, Bell JS, Hallikainen I, Koivisto AM.

Int Psychogeriatr. 2017 Oct;29(10):1723-1733. doi: 10.1017/S1041610217001090. Epub 2017 Jun 19.

Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery

Uliassi E, Gandini A, Perone RC, Bolognesi ML.

Future Med Chem. 2017 Jun;9(10):995-1013. doi: 10.4155/fmc-2017-0038. Epub 2017 Jun 20.

Protective effects of flavonoids against Alzheimer's disease-related neural dysfunctions

Bakhtiari M, Panahi Y, Ameli J, Darvishi B.

Biomed Pharmacother. 2017 Sep;93:218-229. doi: 10.1016/j.biopha.2017.06.010. Epub 2017 Jun 20.

Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives

Femminella GD, Bencivenga L, Petraglia L, Visaggi L, Gioia L, Grieco FV, de Lucia C, Komici K, Corbi G, Edison P, Rengo G, Ferrara N.

J Diabetes Res. 2017;2017:7420796. doi: 10.1155/2017/7420796. Epub 2017 Jun 1.

Recent developments in biological activities of indanones

Patil SA, Patil R, Patil SA.

Eur J Med Chem. 2017 Sep 29;138:182-198. doi: 10.1016/j.ejmech.2017.06.032. Epub 2017 Jun 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias